Objective: Whether the aortopathy associated with bicuspid aortic valve (BAV) disease occurs secondary to genetic or hemodynamic factors remains controversial. In this article we describe the natural history of the aortic root in patients with bicuspid versus tricuspid aortic valves (TAVs) after replacement of the aortic valve and ascending aorta.
Results: Mean imaging follow-up was 5.5 (AE5.3) years. Of all patients, 66.5% had at least 1 aortic root measurement after the index operation. Baseline aortic diameter was comparable between groups. In patients with BAV, aortic root diameter increased at a clinically negligible rate over time (0.654 mm per year; 95% confidence interval, 0.291-1.016; P < .001), similar to patients with TAV (P ¼ .92). Mean clinical follow-up was 8.1 (AE5.4) years. During follow-up, 18 patients underwent reoperation, 89% for a degenerated bioprosthetic aortic valve. Only 1 patient underwent reoperation for a primary indication of aortic aneurysmal disease, 22 years after the index operation. There were no differences in cumulative incidence rates of aortic reoperation (P ¼ .14) between patients with BAV and TAV.
Conclusions: Mid-term imaging after aortic valve and ascending aorta replacement indicates that if the aortic root is not dilated at the time of surgery, the risk of enlargement over time is minimal, negating the need for prophylactic root replacement in patients with BAV or TAV. (J Thorac Cardiovasc Surg 2018;156: [5] [6] [7] [8] [9] [10] [11] [12] [13] Aortic root diameter over time after aortic valve and ascending aorta replacement.
Central Message
In patients requiring replacement of the aortic valve and ascending aorta, risk of enlargement of the remaining aortic root over time is minimal, negating the need for prophylactic root replacement.
Perspective
Whether the aortopathy associated with bicuspid aortic valve disease occurs due to genetic or hemodynamic factors remains controversial. This work represents one of the largest natural history studies to date assessing aortic root dimensions with follow-up imaging data and reports minimal enlargement of the sinus segments after replacement of the aortic valve and ascending aorta.
See Editorial Commentaries pages 14 and 16.
See Editorial page 1.
Bicuspid aortic valve (BAV) disease is the most common congenital cardiac abnormality, occurring in approximately 1% to 2% of the general population. 1 Patients with BAV might develop significant valvular dysfunction, with as many as 50% of patients requiring surgical aortic valve From the a replacement (AVR). 2 In addition to pathology of the aortic valve, patients with BAVare 86 times more likely to have proximal aortic aneurysms and 8 times more likely to experience aortic dissection compared with the general population. 3 Aortopathy is estimated to occur in 50% of patients with BAVand progresses with age, affecting as many as 88% to 91% of patients over 50 to 60 years. 1 There are competing hemodynamic versus genetic theories regarding the pathogenesis of aortic dilatation in patients with BAV. [4] [5] [6] [7] Although genetic as well as hemodynamic factors are known to contribute to the heterogeneity of BAV aortopathy, there is no consensus about their degree of involvement, interaction, and implications for surgical guidelines.
Natural history data reporting aortic root dilatation in patients with BAV after surgical AVR and ascending aorta (RAA) is lacking, and is necessary to clarify BAV aortopathy progression. 8 If the risk of aortic root enlargement or of aortic complications is minimal in this cohort over time, this might negate the need for a prophylactic root replacement procedure in these patients. In this retrospective study we describe the natural history of the aortic root after AVR and RAA in patients with BAV compared with patients with tricuspid aortic valve (TAV).
METHODS

Study Population
All patients who underwent first-time combined AVR and RAA at the Peter Munk Cardiac Centre from January 1990 to December 2010 were identified through the cardiovascular surgery database. Patients underwent a full root replacement if the aortic root dimensions exceeded a diameter of 45 mm at the time of surgery. Approximately one-third of study patients also underwent replacement of the noncoronary sinus at the time of AVR and RAA. Indications for replacement of the noncoronary sinus at our institution include asymmetric dilatation of the noncoronary sinus, in particular older patients and those with BAVs without cephalad displacement of the coronary arteries or annuloaortic ectasia. In the early study period, sinus measurements were generally obtained in the long-axis view of aortic root using echocardiography. More recently, gated computed tomography (CT) imaging with sinus-to-sinus (3) and sinus-to-commissure (3) measurements have been used. The largest diameter of the 6 measurements is used to assess root size. However, intraoperative assessment of asymmetry and quality of the tissues also determine whether full root or partial root repair was performed. Isolated replacement of the noncoronary sinus with a patch was also used to facilitate the insertion of a larger prosthesis in patients with a small aortic annulus by permitting supra-annular placement of the valve. During the study period, 1660 patients underwent a full root replacement at our institution. Patients were grouped as either ''hemiarch'' or ''RAA'' to denote the extent and method of proximal aortic replacement (ie, either the ascending aorta was replaced under a period of circulatory arrest with hypothermia with or without cerebral perfusion (hemi-arch), or the cross-clamp was left in place during RAA). We excluded patients with aortic dissection, active endocarditis, connective tissue disorders (Marfan syndrome, Loeys-Dietz syndrome, etc), and those who underwent the Ross procedure (Figure 1 ).
Data Collection and Definitions
Perioperative clinical data were prospectively collected on all patients who underwent cardiac surgery in our institutional database. Operative reports were reviewed to confirm BAV status and cusp fusion type. Patients were contacted via phone or electronically to determine morbid outcomes and to confirm vital status. Imaging data were collected from all available echocardiography, CT, and magnetic resonance imaging (MRI) reports at baseline and during follow-up. Patients' community cardiologists were contacted to obtain clinical follow-up and imaging data. All available aortic root and arch dimension data were collected and analyzed. The Research Ethics Board of the University Health Network approved the study (REB 15-9164) and waived the need for individual patient consent.
Statistical Analysis Descriptive analysis. Clinical characteristics were summarized in terms of medians (interquartile ranges) for continuous variable and frequencies for dichotomous and polytomous variables. Between-group differences in continuous variables were assessed using Wilcoxon rank-sum tests, and differences in dichotomous/polytomous variables were assessed using Fisher exact tests.
Longitudinal image analysis. We considered all available imaging data (MRI, CT, and echocardiography) collected longitudinally after the index operation and analyzed the imaging data using generalized least square methods. The breakdown of imaging data according to modality is reported in Table E1 . The outcome variables were root dimension over time. The independent variables of interest included the cohort variable (BAV vs TAV), time of the imaging study (measured according to years since the index operation), and their interactions. We also considered age, sex, body surface area, and baseline aortic root dimension immediately after the index operation as control variables. Because of the small number of patients with serial imaging data, we were unable to account for other clinical variables. To account for the longitudinal nature of the data and irregular measurement times, we assumed each subject's root dimensions follow a multivariate normal distribution with a compound symmetry covariance structure. We modeled the progression of root dimension nonparametrically using restricted regression spline. The 95% confidence intervals (CIs) and P values were calculated using Rubin's rule to combine regression results from multiple imputed data sets.
Multivariate analysis. Postoperative mortality was analyzed using multivariable Cox regression, stratified according to the period of the index operation (1995 or before, 1996-2000, 2001-2005, 2006-2010) . Clinical risk factors and operative information were considered in the regression model. Risk factor analysis was conducted using stepwise variable selection on the basis of Akaike information criteria. All predictors, except the cohort variable, were subject to variable selection. To assess the reliability of the stepwise variable selection, the bootstrap method was used. Aortic reoperation was analyzed using cause-specific hazard regression models, stratified according to the year of the index operation. Because of the small number of patients with aortic reoperation, the regression
Abbreviations and Acronyms
AVR ¼ aortic valve replacement BAV ¼ bicuspid aortic valve CI ¼ confidence interval CT ¼ computed tomography HR ¼ hazard ratio MRI ¼ magnetic resonance imaging RAA ¼ replacement of the ascending aorta TAV ¼ tricuspid aortic valve models for reoperation included only age and sex, and no risk factor analysis was conducted. Analyses were conducted using R version 3.3.2 (https://www.r-project.org).
RESULTS
Baseline Characteristics
From 1990 to 2010, 406 patients were identified who underwent first-time replacement of their aortic valve and ascending aorta at the Peter Munk Cardiac Centre. The baseline characteristics of the final study cohort are shown in Table 1 . Among this cohort, 269 patients (66.3%) had BAV and 137 patients (33.7%) had TAV. The mean age of the cohort was 66 (58-73) years and 69.2% were male. Most patients (62.1%) had aortic stenosis at the time of surgery and most (64.3%) received a bioprosthetic aortic valve. The overall mean size of the ascending aorta at the time of index operation was 46 AE 7 mm. In addition to AVR and RAA, 43.1% of the patients in the study also underwent surgical replacement of the proximal arch under circulatory arrest during the index operation.
As expected, patients with BAV were significantly younger than those with TAV (BAV: 65 [range, 55-71] vs TAV: 70 [range, 65-76] years; P < .001) and more were male (BAV: 74.7% vs TAV: 58.4%; P <.001). More patients with BAV had replacement of the noncoronary sinus at the time of surgery (BAV: 36.1% vs TAV 19.7%; P < .001), but fewer underwent use of circulatory arrest for an open distal anastomosis (BAV: 38.3% vs TAV 52.6%; P < .001). Operative details and early outcomes are summarized in Tables 2 and 3 .
Aortic Root Imaging
The mean follow-up time for the imaging studies was 5.5 AE 5.3 years and the maximum follow-up was 19.8 years. The baseline aortic root diameter was comparable between groups (BAV: 33 AE 5 mm, TAV: 32 AE 6 mm; P ¼ .41). Of the BAV patients, 70.6% and of the TAV patients, 58.4% had at least 1 measurement of the root after the index operation. Statistical analysis of all available imaging reports (echocardiogram, CT, and MRI) revealed that in patients with BAV, the aortic root diameter increased at a small but clinically negligible rate over time (0.654 mm per year 95% CI, 0.291-1.016; P < .001), which was not different compared with patients with TAV (P ¼ .92; Figure 2 ). Baseline aortic root diameter did not significantly affect growth, assessed using the generalized least squares model and according to interaction with growth rate (P ¼ .34).
Aortic Arch Imaging
Baseline aortic arch diameter was comparable between groups (BAV: 31 AE 8 mm; TAV: 32 AE 5 mm; P ¼ .46). There were 75 (BAV: 50, TAV: 25) patients with at least 1 measurement of the aortic arch after the index operation. The aortic arch dimension at last known follow-up was similar between groups (BAV: 30 AE 5 mm vs TAV: 30 AE 7 mm; P ¼ .89) and was not different between those who had undergone aortic replacement with a cross-clamp in place or under circulatory arrest (RAA: 30 AE 5 mm vs hemi-arch: 30 AE 6 mm; P ¼ .93).
Mid-Term Outcomes
Follow-up was complete (until 2013 to 2015 or death) for 316 patients (77.8%). The mean (SD) follow-up time was 8.1 AE 5.4 years amounting to 3278.9 patient-years. After adjusting for baseline characteristics, patients with BAV had a similar risk of long-term mortality compared with those with TAV (hazard ratio [HR], 0.74; 95% CI, 0.49-1.12; P ¼ .16).
During the follow-up period, 18 (BAV: 13, TAV: 5) patients underwent a cardiac reoperation, most of which (89%) were for a degenerated bioprosthetic aortic valve (Table E2) . At the time of cardiac reoperation, 10 patients had their aortic root replaced and 2 also had their arch replaced. Of the 406 patients in the study cohort, only 1 patient underwent a cardiac reoperation for a primary indication of aortic aneurysmal disease 22 years after the index operation. There were no differences in cumulative incidence rates of cardiac (P ¼ .37) or aortic reoperation (P ¼ .14) between patients with BAV and TAV (Figure 3) . After adjusting for age and sex, the risk of any cardiovascular reoperation (HR, 0.29; P ¼ .62) or any aortic reoperation (HR, 0.88; P ¼ .27) was similar in both groups.
DISCUSSION
Development and progression of aortopathy in patients with BAV is likely because of a combination of hemodynamic and genetic factors. [4] [5] [6] A genetic basis for BAV aortopathy 9, 10 and progressive enlargement of the aorta after AVR has been observed. 11 A study analyzing longterm outcomes in patients who underwent BAV surgery suggests that an aortic diameter >4.5 cm or cross-sectional area-to-height ratio >8 is associated with ascending aortic events, meriting surgical repair. 12 Although guidelines have recently increased the size threshold for prophylactic aortic repair in BAV, [13] [14] [15] some groups advocate for aggressive replacement of the aortic root and proximal arch in patients with BAV who present with aortic valve disease and aneurysms limited to the ascending aorta. [16] [17] [18] Conversely, other studies show no dilatation of the aortic root or ascending aorta after AVR in patients with BAV compared with patients with TAV or the general population. [19] [20] [21] Itagaki et al showed that patients with BAV develop significantly less aortic dilatation after AVR compared with patients with Marfan syndrome. 22 These reports suggest that replacement of the diseased bicuspid valve might prevent future aortic disease by treating hemodynamic factors, negating the need for prophylactic resection of the aorta. An important limitation of these studies was that patients with BAV did not have known aortopathy at the time of surgery. Natural history data on the aortic root in patients with BAV have been limited. Park and colleagues showed very low rates of aortic reoperation and no enlargement of the aortic root in patients with BAV after AVR and RAA. However, this was on the basis of limited echocardiography data from a small cohort of patients (n ¼ 34) with a mean followup of 3.3 years. 23 This investigation had a significantly larger sample size of imaging data and incorporated imaging at multiple time points over the follow-up period. Our findings of a negligible growth rate of the aortic root in patients with BAV are supported by other recent studies with comparable observations. 24, 25 Considering the mean age of the patients in this study, neither patients with BAV nor TAV are likely to require surgical intervention for aortic root aneurysm after AVR and RAA. Overall, these data support the current surgical strategy and indicate that patients might not need prophylactic replacement of a nonaneurysmal aortic root.
It should be noted that the management of the aortic root is complex and includes the consideration of several factors other than absolute aortic dimensions. Additional determinants include the patient's age and comorbidities, degree and rate of root dilatation, number of sinuses involved, cephalad displacement of the coronary ostia, quality of aortic tissue, patient preference for tissue or mechanical valve, surgical proficiency with root replacement procedures, need for concomitant coronary bypass grafting or complex arch reconstruction, and likelihood of redo cardiac surgery or transcatheter valve-in-valve AVR in the future. 26 These factors all influence a surgeon's decision regarding how much, if any, of the aortic root should be replaced. The aortic arch might also become aneurysmal in patients with BAV, 27 leading some groups to recommend replacing the proximal arch under circulatory arrest prophylactically in patients with BAV undergoing RAA. 28 Park et al showed no significant difference in arch diameter using echocardiography in patients with BAV after AVR or RAA in 58 patients with a median follow-up time of 4 years. 29 A study by Abdulkareem et al showed no significant dilatation of the arch after RAA in patients with BAV compared with patients with TAV at 5 years after the index operation. 19 Accordingly, this study showed that arch diameter at last known follow-up was not different after AVR and RAA in patients with BAV compared with those with TAV. Furthermore, arch dimensions were not different between patients who underwent hemi-arch procedures and those who had a cross-clamp left in place during replacement of their ascending aorta clamp, supporting the current surgical approach to the arch.
LIMITATION
The main limitations of this study are the sample size and incomplete mid-term imaging follow-up. A prospectively designed study with complete imaging follow-up for a longer duration of time would provide more definitive data. Certain BAV fusion types are associated with different presentations of aortopathy. [30] [31] [32] However, we did not have a large enough sample size to examine aortic size progression according to BAV fusion type. Similarly, most patients in our study had a stenotic aortic valve and we were unable to identify those with a root phenotype (annuloaortic ectasia and aortic insufficiency), who would be more at risk of an aortic root aneurysm. 33, 34 Last, arch measurements were reported at last known follow-up, Data are presented as n (%) except where otherwise noted. BAV, Bicuspid aortic valve; TAV, tricuspid aortic valve.
FIGURE 2. Aortic root diameter over time in patients with aortic valve and ascending aorta replacement. Using the generalized least squared method, it was observed that the aortic root increased by 0.6554 mm per year (95% CI, 0.291-1.016; P < .001) in patients with BAV and by 0.825 mm per year (95% CI, 0.181-1.469; P ¼ .012) in patients with TAV. The differential progression rate between patients with BAV and TAV (ie, the difference in the slopes) was not statistically significant (P ¼ .92). TAV, Tricuspid aortic valve; BAV, bicuspid aortic valve.
FIGURE 3. Aortic reoperation over time in patients with aortic valve and ascending aorta replacement. The cumulative incidence rates of aortic reoperation were summarized. Gray's test was applied to assess differences between cohorts. There was no significant difference in cumulative incidence rates of aortic reoperation in patients with BAV compared with TAV (P ¼ .14). TAV, Tricuspid aortic valve; BAV, bicuspid aortic valve.
which is a different time point for each patient and therefore not directly comparable. The limited number of available arch measurements made it such that it was not possible to report a growth rate or arch measurements at a single time point. Baseline arch dimensions, however, were small and not different between groups and no patient experienced significant aneurysmal degeneration of the arch during the follow-up period. These observations should be considered preliminary until confirmed by larger studies with longer and more complete follow-up. Our aortic measurements came from multiple imaging modalities and there might be systematic differences in how these are reported. Differences in measurements between imaging modalities is likely to have a minimal effect on our findings regarding the aortic root, because 98.5% of measurements were from echocardiography. The limited numbers of imaging measurements of the arch precluded meaningful statistical comparison according to modality. Additionally, imaging reports were from multiple institutions and the effect of interassessor variability was not formally assessed. A prospective study limited to a single imaging modality with a clearly specified location for aortic measurements and an interpreter blinded to patient groups would be ideal.
Finally, a significant proportion of our study cohort underwent surgical replacement of the noncoronary sinus as part of their index operation, which might have altered the natural progression of aortic root growth over time. Despite these limitations, this retrospective study constitutes the one of the most robust investigations to date to assess aortic root dimensions over time in patients with BAV after AVR and RAA.
CONCLUSIONS
The most important finding of this study is that in patients with normal root size after AVR for aortic stenosis with concomitant RAA with or without noncoronary sinus, mid-term imaging and clinical outcomes suggest the aortic root does not increase in size significantly over time in patients with either BAVor TAV (Video 1). Our study has validated the current surgical strategy of replacing frankly aneurysmal aortic tissue (>45 mm) at the time of AVR as a durable one. Prophylactically replacing the aortic root with normal dimensions or mild dilatation in patients with BAVor TAV for the theoretical risk of future sinus dilatation does not appear to be justified, because the risk of enlargement and aneurysm complications over time is minimal.
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Authors have nothing to disclose with regard to commercial support. Bicuspid aortopathy is a very complex topic. Beyond the genetic versus biomechanical etiologic hypotheses, one might also consider the at least 3 3 3 box of permutations of normal, stenotic, and regurgitant valves against normal, aneurysmal, and dissected aorta, and the 8 conditions or more generated, which might require intervention involving multiple forms of valvular repair or replacement and aortic replacement, and this is without considering aortic phenotypic variance.
This study elegantly focused on the natural history of, essentially, a mean normal-sized 3.6-cm aortic root and a mean normal-sized 3.3-cm aortic arch in patients with bicuspid or tricuspid aortic valve disease and ascending aortic aneurysm, undergoing AVR and ascending aortic replacement and, occasionally, noncoronary sinus replacement. The group observed minimal growth of and, ostensibly, no need for reoperation for the unreplaced aorta.
I have 4 simple questions, with a primary goal of trying to give surgeons some practical guidance. What was the mean size of the ascending aorta that was replaced?
Dr Sonya K. Hui (Toronto, Ontario, Canada). The mean size of the ascending aorta in our entire study cohort was 4.6 cm. Dr Woo. Thank you. During the same time period, do you have a sense of how many patients underwent a full root replacement and was there a diameter threshold for the root to need to undergo that replacement?
Dr Hui. Thank you for your insightful questions. In terms of your first question, I can't speak to that; I wasn't a surgeon at our institution during that time.
Dr Woo. But you may be some day. Dr Hui. Maybe some day. And then for your second question, sorry, can you repeat that? Dr Woo. Is there basically a size threshold of the aortic root that would prompt the surgeons to replace all of the sinuses?
Dr Hui. At our institution, at the Toronto General Hospital, the threshold used for surgical intervention of replacing both the root or ascending aorta in patients who need to undergo an aortic valve replacement is 45 mm or 4.5 cm.
Dr Woo. Was there a sense that there were perhaps a substantive number of patients who underwent a reoperation at 13.e1 The Journal of Thoracic and Cardiovascular Surgery c July 2018
